Disability Benefits for Sarcoidosis

How SSA Evaluates Sarcoidosis Under Listing 3.02

Sarcoidosis causes clusters of inflammatory cells (granulomas) to form in the body, most often in the lungs. When it affects the lungs, SSA evaluates it under Blue Book listing 3.02 for chronic respiratory disorders, which relies on objective breathing tests.

Ways to Meet the Listing

Pulmonary sarcoidosis can meet listing 3.02 through:

• FEV1 (3.02A) — forced expiratory volume in one second at or below the value listed for your height and gender.
• FVC (3.02B) — forced vital capacity at or below the listed value.
• Impaired gas exchange (3.02C) — a low diffusing capacity (DLCO), or arterial blood gas or oxygen saturation results at or below the listed levels.

Because sarcoidosis can cause scarring and stiffness in the lungs, it often reduces lung volumes and gas exchange, so the FVC and DLCO paths can be especially relevant. Sarcoidosis is a multi-system disease, however, and it may affect organs beyond the lungs. When it does, SSA evaluates those effects under the appropriate listings — for example, the heart under section 4.00, the eyes under section 2.00, the skin under section 8.00, and the nervous system under section 11.00. Neurosarcoidosis and cardiac sarcoidosis in particular can be serious. SSA considers the combined effect of sarcoidosis across every body system it involves, so documenting all affected organs is important, and it reviews testing over time rather than a single result.

Medical Evidence for a Sarcoidosis Claim

Because sarcoidosis can affect many organs, a well-rounded record is essential. SSA will look for:

• Pulmonary function tests — spirometry and DLCO — and chest imaging documenting lung involvement.
• Biopsy results confirming the diagnosis, when available.
• Organ-specific testing — cardiac studies, eye examinations, skin notes, or neurological imaging if those systems are involved.
• Treatment records — corticosteroids or other medications and your response.
• Symptom history documenting fatigue, breathlessness, and other system-specific problems.

Ask your doctors to describe how sarcoidosis limits your exertion, stamina, and daily activities across every affected system. Because sarcoidosis varies so widely and the profound fatigue it causes is easy to overlook, a record that captures both lung function and every other organ involved gives SSA the fullest and most credible picture of your claim.

Qualifying Through an RFC Assessment

When sarcoidosis does not meet a listing exactly, SSA assesses residual functional capacity (RFC), weighing all of its effects together. Lung involvement causes shortness of breath and reduced stamina that limit walking, standing, and lifting, while the deep fatigue common in sarcoidosis can require unscheduled rest. Heart involvement may limit exertion further, and eye, skin, or nerve problems add their own restrictions.

Exposure to dust, fumes, and temperature extremes can worsen breathing symptoms. SSA combines these limits into an RFC — often reduced exertion, environmental restrictions, and extra breaks — and compares it to your past work. If you cannot return to that work, the medical-vocational rules may direct a finding of disabled, especially for claimants age 50 and older. Because sarcoidosis can flare and remit and often requires ongoing treatment, frequent appointments and unpredictable symptoms can also cause absences that make sustained full-time work difficult.

Tips for a Stronger Sarcoidosis Claim

• Document every affected organ. Sarcoidosis is multi-system, so records for the heart, eyes, skin, and nerves can all support the claim.
• Include lung testing. Spirometry and DLCO document pulmonary involvement under listing 3.02.
• Report fatigue honestly. The profound fatigue of sarcoidosis is central but only helps if it is written down.
• Note medication effects, since long-term steroids bring their own limitations.
• Stay in consistent care so flares, treatment, and progression are documented over time.